Join us for a live broadcast on Monday, April 7, 2025, from 7:30 – 8:30 PM ET, featuring Dr. John Marshall and moderated by Dr. Cynthia Seow. They will discuss the latest evidence on the use of IL-23 inhibitors in treating ulcerative colitis. Don't miss this informative session! Register below!

VIRTUAL EVENT

Monday, April 7, 2025
7:30 - 8:30 PM Eastern Time
Monday
April 7, 2025
7:30 pm - 8:30 pm EST

SPEAKER


John MarshallMD, MSc, FRCPC, CAGF, AGAF
Professor of Medicine
Director, Division of Gastroenterology
McMaster University
Hamilton, Ontario
Show Bio

MODERATOR


Cynthia SeowMBBS (Hons), MSc, FRACP
Professor
Division of Gastroenterology & Hepatology
Departments of Medicine & Community Health Sciences
University of Calgary
Calgary, Alberta
Show Bio

LEARNING OBJECTIVES


At the conclusion of this program, participants should be better able to:
  • Explain the mechanism of action of IL-23p19 inhibitors for UC and how this is different from other approved advanced therapies
  • Describe the clinical trial evidence of efficacy and safety with the IL-23p19 inhibitors approved—or under development for—the treatment of UC
  • Identify patients with UC who would benefit from the use of IL-23p19 inhibitors for induction and/or maintenance treatment

Please enter your information below to register for this virtual event








Please bring your own device to participate in the interactive portion of this program